Abstract Objectives-To document the variety of liver diseases and the clinical picture of hepatic hypertrophic osteoarthropathy
Hepatic hypertrophic osteoarthropathy (HOA) was originally described in 1895' and is characterised by periosteal reactions affecting the shafts of long bones. It is well documented from case reports2-1 in studies involving larger groups of patients.7 8 Hepatic HOA with arthritis, however, is rare and only three cases are recorded in the largest series. 7 This paper describes seven patients from a liver transplant centre suffering from hepatic HOA with arthritis.
Case reports
The clinical details of the patients are given in the table.
All patients received post-transplantation immunosuppression with azathioprine 1 mgm/ kgm, cyclosporin 5 mgm/kgm and high dose prednisolone.
CASES 1 AND 2
Two female children required Kasai procedures in infancy for biliary atresia. This operation involves excision of the extrahepatic biliary tree and construction of a roux-en-y loop to the remaining biliary tree in an attempt to reduce intrahepatic cholestasis. Unfortunately, both eventually required liver transplantation.
Nine months before transplantation, patient 1 presented with painful knees with effusion and slight swelling of both elbows. Radiographs of the elbows showed obvious periostitis and three months later she was wheelchair dependant because of severe knee pain. was clubbed and there was a right knee effusion as well as tenderness to palpation of the bones just above the ankles and wrists.
Discussion
These reported patients with hepatic HOA and arthritis suffered from a variety of liver diseases. They are representative of patients referred to the liver unit for transplantation where 25% suffer PBC, 7% biliary atresia, 5% primary sclerosing cholangitis, 4% alcoholic cirrhosis and 59% other causes including acute Wilson's disease. This contrasts with Epstein's original report7 where PBC was the diagnosis in 50% of cases of hepatic HOA.
All patients were clubbed compared with 30/o of patients undergoing hepatic transplantation in the unit and the arthritis was universally characterised by knee effusion. There was also involvement of other joints including ankles, wrists and elbows. In all cases, the arthritis was associated with considerable morbidity which resulted in pain and limitation of movement. Conservative management including injection with corticosteroid and the use of non-steroidal anti-inflammatory drugs was of no benefit to any patient.
The age of the patients at presentation of the arthritis ranged from 11 to 44 years and in five of the seven cases joint symptoms were most severe immediately pre liver transplantation, occurring at a time of marked liver decompensation. In patient 3 it is very probable that arthritis preceded transplantation as she was wheelchair dependant immediately following surgery. The presentation of arthritis at a time of severe liver decompensation is highlighted in the literature by a report of arthritis first presenting at the time of liver transplant rejection9 and it is interesting that case 5, where graft function was inadequate, continues to have severely painful swollen knees.
Of the six patients undergoing transplantation, a successful graft was achieved in four, and in these there was complete resolution of symptoms between three days and 18 months. This observation is supported by the report of another centre'0 where two patients with hepatic HOA, one with crippling arthritis, had complete resolution of their symptoms following transplantation.
In the patients reported here arthritis occurred in six of the seven cases at a time of severe liver decompensation and in four patients, in whom liver transplantation was successful, the symptoms resolved.
In case 5, despite immunosuppression, arthritis has persisted, and it is unlikely that such treatment explains the resolution of the arthritis. In cases 1 and 2 pretransplant bacterial overgrowth, implicated in the pathogenesis of arthritis in gastrointestinal bypass surgery, is not responsible for arthritis as the roux-en-y loop is not distended so the patient does not have the features of 'blind loop'.
To date there is no UK report documenting resolution of HOA in patients undergoing cardiac or heart and lung transplantation.
It appears therefore that the damaged liver produces or fails to metabolise substances responsible for the local changes in bone metabolism in these patients with arthritis and HOA.
Conclusion
This paper reports the clinical picture of arthritis in patients with a variety of liver diseases complicated by HOA. The observation that successful liver transplantation is associated with a resolution of pain and joint effusion is interesting and warrants further investigation.
